Issue 364: Dupixent Lawsuits Now Under Investigation
October 29, 2025 — Issue #364In this issue, we have information about Dupixent, an injectable drug used to treat eczema, asthma, and more, and how it may be linked to a very specific form of T-cell lymphoma.